Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Trbusek

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Haematologica|April 16, 2013
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicinVeronika Navrkalova, Ludmila Sebejova, Jana Zemanova, et al.
Blood|August 3, 2016
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Pavlasova, Marek Borsky, Vaclav Seda, et al.
Oncotarget|August 25, 2016
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cellsJana Zemanova, Ondrej Hylse, Jana Collakova, et al.
Leukemia|August 17, 2018
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cellsKaterina Cerna, Jan Oppelt, Vaclav Chochola, et al.
Blood|October 24, 2009
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damageJitka Malcikova, Jana Smardova, Ludmila Rocnova, et al.
British Journal of Haematology|July 30, 2016
Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patientsBarbara Kantorova, Jitka Malcikova, Kamila Brazdilova, et al.
Blood|January 12, 2012
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemiaMarek Mraz, Dasa Dolezalova, Karla Plevova, et al.
BMC Cancer|February 4, 2022
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changesHelena Olbertova, Karla Plevova, Sarka Pavlova, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 21, 2014
TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methodsBarbara Kantorova, Jitka Malcikova, Jana Smardova, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Haematologica|April 16, 2013
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicinVeronika Navrkalova, Ludmila Sebejova, Jana Zemanova, et al.
Blood|August 3, 2016
Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axisGabriela Pavlasova, Marek Borsky, Vaclav Seda, et al.
Oncotarget|August 25, 2016
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cellsJana Zemanova, Ondrej Hylse, Jana Collakova, et al.
Leukemia|August 17, 2018
MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cellsKaterina Cerna, Jan Oppelt, Vaclav Chochola, et al.
Blood|October 24, 2009
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damageJitka Malcikova, Jana Smardova, Ludmila Rocnova, et al.
British Journal of Haematology|July 30, 2016
Single cell analysis revealed a coexistence of NOTCH1 and TP53 mutations within the same cancer cells in chronic lymphocytic leukaemia patientsBarbara Kantorova, Jitka Malcikova, Kamila Brazdilova, et al.
Blood|January 12, 2012
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemiaMarek Mraz, Dasa Dolezalova, Karla Plevova, et al.
BMC Cancer|February 4, 2022
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changesHelena Olbertova, Karla Plevova, Sarka Pavlova, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 21, 2014
TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methodsBarbara Kantorova, Jitka Malcikova, Jana Smardova, et al.
Haematologica|December 7, 2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical settingLesley-Ann Sutton, Viktor Ljungström, Larry Mansouri, et al.
Pageof 4